Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

475 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease.
Emmi G, Silvestri E, Bella CD, Grassi A, Benagiano M, Cianchi F, Squatrito D, Cantarini L, Emmi L, Selmi C, Prisco D, D'Elios MM. Emmi G, et al. Among authors: cantarini l. Medicine (Baltimore). 2016 Dec;95(49):e5516. doi: 10.1097/MD.0000000000005516. Medicine (Baltimore). 2016. PMID: 27930541 Free PMC article.
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α.
Castrichini M, Lazzerini PE, Gamberucci A, Capecchi PL, Franceschini R, Natale M, Hammoud M, Moramarco A, Zimbone S, Gianchecchi E, Montilli C, Ricci G, Selvi E, Cantarini L, Galeazzi M, Laghi-Pasini F. Castrichini M, et al. Among authors: cantarini l. Eur J Immunol. 2014 Jan;44(1):227-38. doi: 10.1002/eji.201343353. Epub 2013 Oct 24. Eur J Immunol. 2014. PMID: 24105615 Free article.
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome.
Rigante D, Lopalco G, Vitale A, Lucherini OM, De Clemente C, Caso F, Emmi G, Costa L, Silvestri E, Andreozzi L, Iannone F, Galeazzi M, Cantarini L. Rigante D, et al. Among authors: cantarini l. Clin Rheumatol. 2014 Sep;33(9):1197-207. doi: 10.1007/s10067-014-2722-z. Epub 2014 Jun 17. Clin Rheumatol. 2014. PMID: 24935411 Review.
Biological treatments in Behçet's disease: beyond anti-TNF therapy.
Caso F, Costa L, Rigante D, Lucherini OM, Caso P, Bascherini V, Frediani B, Cimaz R, Marrani E, Nieves-Martín L, Atteno M, Raffaele CG, Tarantino G, Galeazzi M, Punzi L, Cantarini L. Caso F, et al. Among authors: cantarini l. Mediators Inflamm. 2014;2014:107421. doi: 10.1155/2014/107421. Epub 2014 Jun 30. Mediators Inflamm. 2014. PMID: 25061259 Free PMC article. Review.
Safety issues and concerns of new immunomodulators in rheumatology.
Selmi C, Ceribelli A, Naguwa SM, Cantarini L, Shoenfeld Y. Selmi C, et al. Among authors: cantarini l. Expert Opin Drug Saf. 2015 Mar;14(3):389-99. doi: 10.1517/14740338.2015.993605. Epub 2014 Dec 18. Expert Opin Drug Saf. 2015. PMID: 25518908 Review.
PFAPA syndrome and Behçet's disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists.
Cantarini L, Vitale A, Bersani G, Nieves LM, Cattalini M, Lopalco G, Caso F, Costa L, Iannone F, Lapadula G, Galeazzi M, Ceribelli A, Brunetta E, Selmi C, Rigante D. Cantarini L, et al. Clin Rheumatol. 2016 Feb;35(2):501-5. doi: 10.1007/s10067-015-2890-5. Epub 2015 Feb 10. Clin Rheumatol. 2016. PMID: 25665824
475 results